Novo Integrated Sciences announced that the Company will undertake a reverse stock split of its common stock at a ratio of 1-for-10. The Reverse Stock Split is expected to become effective immediately after the close of trading on the Nasdaq Capital Market on November 6, 2023 and the Company’s common stock is expected to begin trading on Nasdaq on a Reverse Stock Split-adjusted basis on November 7, 2023, under the new CUSIP number, 67011T300.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NVOS: